These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 9758365

  • 1. Seprase, a membrane-bound protease, is overexpressed by invasive ductal carcinoma cells of human breast cancers.
    Kelly T, Kechelava S, Rozypal TL, West KW, Korourian S.
    Mod Pathol; 1998 Sep; 11(9):855-63. PubMed ID: 9758365
    [Abstract] [Full Text] [Related]

  • 2. The expression of a type II transmembrane serine protease (Seprase) in human gastric carcinoma.
    Mori Y, Kono K, Matsumoto Y, Fujii H, Yamane T, Mitsumata M, Chen WT.
    Oncology; 2004 Sep; 67(5-6):411-9. PubMed ID: 15713998
    [Abstract] [Full Text] [Related]

  • 3. Inhibin/activin subunits (inhibin-alpha, -betaA and -betaB) are differentially expressed in human breast cancer and their metastasis.
    Mylonas I, Jeschke U, Shabani N, Kuhn C, Friese K, Gerber B.
    Oncol Rep; 2005 Jan; 13(1):81-8. PubMed ID: 15583806
    [Abstract] [Full Text] [Related]

  • 4. Expression of seprase in effusions from patients with epithelial ovarian carcinoma.
    Zhang MZ, Qiao YH, Nesland JM, Trope C, Kennedy A, Chen WT, Suo ZH.
    Chin Med J (Engl); 2007 Apr 20; 120(8):663-8. PubMed ID: 17517181
    [Abstract] [Full Text] [Related]

  • 5. A potential marker protease of invasiveness, seprase, is localized on invadopodia of human malignant melanoma cells.
    Monsky WL, Lin CY, Aoyama A, Kelly T, Akiyama SK, Mueller SC, Chen WT.
    Cancer Res; 1994 Nov 01; 54(21):5702-10. PubMed ID: 7923219
    [Abstract] [Full Text] [Related]

  • 6. Stromelysin 3: an independent prognostic factor for relapse-free survival in node-positive breast cancer and demonstration of novel breast carcinoma cell expression.
    Ahmad A, Hanby A, Dublin E, Poulsom R, Smith P, Barnes D, Rubens R, Anglard P, Hart I.
    Am J Pathol; 1998 Mar 01; 152(3):721-8. PubMed ID: 9502414
    [Abstract] [Full Text] [Related]

  • 7. Seprase, dipeptidyl peptidase IV and urokinase-type plasminogen activator expression in dysplasia and invasive squamous cell carcinoma of the esophagus. A study of 229 cases from Anyang Tumor Hospital, Henan Province, China.
    Goscinski MA, Suo ZH, Nesland JM, Chen WT, Zakrzewska M, Wang J, Zhang S, Flørenes VA, Giercksky KE.
    Oncology; 2008 Mar 01; 75(1-2):49-59. PubMed ID: 18787344
    [Abstract] [Full Text] [Related]

  • 8. Localization of mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase type II in human breast and its disorders.
    Sasano H, Frost AR, Saitoh R, Matsunaga G, Nagura H, Krozowski ZS, Silverberg SG.
    Anticancer Res; 1997 Mar 01; 17(3C):2001-7. PubMed ID: 9216657
    [Abstract] [Full Text] [Related]

  • 9. Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.
    Xu R, Perle MA, Inghirami G, Chan W, Delgado Y, Feiner H.
    Mod Pathol; 2002 Feb 01; 15(2):116-24. PubMed ID: 11850540
    [Abstract] [Full Text] [Related]

  • 10. Correlation of cyclooxygenase-2 and aromatase immunohistochemical expression in invasive ductal carcinoma, ductal carcinoma in situ, and adjacent normal epithelium.
    Oliveira VM, Piato S, Silva MA.
    Breast Cancer Res Treat; 2006 Feb 01; 95(3):235-41. PubMed ID: 16322898
    [Abstract] [Full Text] [Related]

  • 11. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR, Abd-Elwahed SR, Abdulwahed AR.
    Cell Biol Int; 2008 Jun 01; 32(6):698-707. PubMed ID: 18296077
    [Abstract] [Full Text] [Related]

  • 12. Localization of thrombospondin and its cysteine-serine-valine-threonine-cysteine-glycine-specific receptor in human breast carcinoma.
    Tuszynski GP, Nicosia RF.
    Lab Invest; 1994 Feb 01; 70(2):228-33. PubMed ID: 7511188
    [Abstract] [Full Text] [Related]

  • 13. Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence.
    Jeschke U, Mylonas I, Kuhn C, Shabani N, Kunert-Keil C, Schindlbeck C, Gerber B, Friese K.
    Anticancer Res; 2007 Feb 01; 27(4A):1969-74. PubMed ID: 17649807
    [Abstract] [Full Text] [Related]

  • 14. Stromal expression of fibroblast activation protein/seprase, a cell membrane serine proteinase and gelatinase, is associated with longer survival in patients with invasive ductal carcinoma of breast.
    Ariga N, Sato E, Ohuchi N, Nagura H, Ohtani H.
    Int J Cancer; 2001 Jan 20; 95(1):67-72. PubMed ID: 11241314
    [Abstract] [Full Text] [Related]

  • 15. Focal adhesion proteins as markers of malignant transformation and prognostic indicators in breast carcinoma.
    Madan R, Smolkin MB, Cocker R, Fayyad R, Oktay MH.
    Hum Pathol; 2006 Jan 20; 37(1):9-15. PubMed ID: 16360410
    [Abstract] [Full Text] [Related]

  • 16. Tissue distribution of major matrix metalloproteinases and their transcripts in human breast carcinomas.
    Lebeau A, Nerlich AG, Sauer U, Lichtinghagen R, Löhrs U.
    Anticancer Res; 1999 Jan 20; 19(5B):4257-64. PubMed ID: 10628384
    [Abstract] [Full Text] [Related]

  • 17. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.
    Half E, Tang XM, Gwyn K, Sahin A, Wathen K, Sinicrope FA.
    Cancer Res; 2002 Mar 15; 62(6):1676-81. PubMed ID: 11912139
    [Abstract] [Full Text] [Related]

  • 18. Relaxin-like factor (RLF) is differentially expressed in the normal and neoplastic human mammary gland.
    Hombach-Klonisch S, Buchmann J, Sarun S, Fischer B, Klonisch T.
    Cancer; 2000 Dec 01; 89(11):2161-8. PubMed ID: 11147585
    [Abstract] [Full Text] [Related]

  • 19. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
    Jeschke U, Mylonas I, Shabani N, Kunert-Keil C, Schindlbeck C, Gerber B, Friese K.
    Anticancer Res; 2005 Dec 01; 25(3A):1615-22. PubMed ID: 16033070
    [Abstract] [Full Text] [Related]

  • 20. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
    D'Andrea MR, Limiti MR, Bari M, Zambenedetti P, Montagutti A, Ricci F, Pappagallo GL, Sartori D, Vinante O, Mingazzini PL.
    Breast Cancer Res Treat; 2007 Mar 01; 101(3):279-84. PubMed ID: 16835704
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.